Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Context TherapeuticsCNTX | Open-market buy | 25/06/09 | 25/06/10 | 100,000 sh | $0.70 | $70,000 | +12.2% | |
Context TherapeuticsCNTX | Open-market buy | 25/06/06 | 25/06/10 | 40,010 sh | $0.64 | $25,606.4 | +100.0% | |
Alex C. LevitChief Legal Officer, Corp. Sec | Context TherapeuticsCNTX | Open-market buy | 25/06/06 | 25/06/10 | 20,000 sh | $0.58 | $11,600 | +222.2% |
Context TherapeuticsCNTX | Open-market buy | 23/02/21 | 23/02/21 | 5,823 sh | $0.84 | $4,891.32 | +3.8% | |
Context TherapeuticsCNTX | Open-market buy | 23/02/13 | 23/02/13 | 5,606 sh | $0.87 | $4,877.22 | +3.8% | |
Context TherapeuticsCNTX | Open-market buy | 23/02/06 | 23/02/06 | 5,040 sh | $0.97 | $4,888.8 | +3.5% | |
Context TherapeuticsCNTX | Open-market buy | 23/01/30 | 23/01/30 | 7,027 sh | $0.70 | $4,918.9 | +5.2% | |
Context TherapeuticsCNTX | Open-market buy | 23/01/23 | 23/01/23 | 6,839 sh | $0.72 | $4,924.08 | +5.3% | |
Context TherapeuticsCNTX | Open-market buy | 23/01/17 | 23/01/18 | 6,783 sh | $0.74 | $5,019.42 | +5.5% |